Palo Alto Investors LP
Filing Date
Global Rank
#1,981
/ 8,232
▲ 22
Top Industry
Biotechnology
83.0%
3Y Alpha vs SPY
-14.1%
Period ended 2 months ago
Filed May 15, 2026 · 30d
25 quarters · since Mar 2020
Clone Performance
Jun 2023–Jun 2026 · vs SPYHypothetical growth of cloning every reported 13F position and rebalancing on each filing, indexed to the same start.
Cloned portfolio
+21.5%
SPY
+76.3%
Annualised alpha
-14.1%
Max drawdown
−35.1%
Estimate. 13F holdings are quarter-lagged and long-only, so the clone rebalances about 45 days after each period end — when the filing becomes public — and excludes options and short positions. Past performance does not predict future results.
Portfolio Concentration
51 positions · as of Mar 31, 2026 · Δ vs Dec 31, 2025Top Position
10.4%
−1.4 pts
Top 5
41.4%
−5.7 pts
Top 10
63.8%
−3.8 pts
HHI
529
Diversified−64
Portfolio Trend
25 quarters · across all stocks
Sector Breakdown
As of Mar 31, 2026| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 99.7% | $651,950,264 |
| Financial Services | 0.3% | $1,912,808 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increased
17 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| ANNX | Annexon, Inc. | +563,898 | 2,948,090 | $16,332,418 | |
| ACAD | Acadia Pharmaceuticals Inc | +388,664 | 2,872,695 | $63,946,190 | |
| BCAX | Bicara Therapeutics Inc. | +251,833 | 550,408 | $10,947,615 | |
| TSHA | Taysha Gene Therapies, Inc. | +208,187 | 1,391,382 | $6,219,477 | |
| DYN | Dyne Therapeutics, Inc. | +180,775 | 1,652,972 | $29,968,382 | |
| MIRM | Mirum Pharmaceuticals, Inc. | +168,754 | 325,175 | $30,039,666 | |
| RARE | Ultragenyx Pharmaceutical Inc. | +135,201 | 596,495 | $12,496,570 | |
| TVTX | Travere Therapeutics, Inc. | +119,734 | 230,453 | $6,846,758 | |
| IRON | Disc Medicine, Inc. | +84,263 | 401,719 | $25,685,912 | |
| SNDX | Syndax Pharmaceuticals Inc | +70,479 | 864,986 | $20,206,072 | |
| CDNA | CareDx, Inc. | +53,650 | 531,870 | $9,233,263 | |
| ACRS | Aclaris Therapeutics, Inc. | +46,590 | 1,613,430 | $6,050,362 | |
| PTCT | Ptc Therapeutics, Inc. | +17,691 | 921,607 | $62,789,084 | |
| STOK | Stoke Therapeutics, Inc. | +12,609 | 84,631 | $2,755,585 | |
| UTHR | UNITED THERAPEUTICS Corp | +4,623 | 62,809 | $37,244,480 | |
| CAPR | Capricor Therapeutics, Inc. | +3,459 | 229,763 | $6,984,795 | |
| AGIO | Agios Pharmaceuticals, Inc. | +1,102 | 213,601 | $7,226,121 | |
| No positions match the current search. | |||||
Trimmed
Positions the filer reduced
17 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| FOLD | AMICUS THERAPEUTICS, INC. | −4,092,722 | 1,113,045 | $16,094,630 | |
| CMPX | Compass Therapeutics, Inc. | −1,017,915 | 1,514,504 | $8,011,726 | |
| IOVA | Iovance Biotherapeutics, Inc. | −767,113 | 6,349,563 | $22,286,966 | |
| DNLI | Denali Therapeutics Inc. | −406,657 | 234,582 | $4,503,974 | |
| PRTA | Prothena Corp Public Ltd Co | −111,942 | 1,208,568 | $11,747,280 | |
| INSM | INSMED Inc | −74,213 | 415,269 | $67,904,786 | |
| ALDX | Aldeyra Therapeutics, Inc. | −69,756 | 155,709 | $263,148 | |
| BMRN | Biomarin Pharmaceutical Inc | −61,074 | 685,182 | $38,705,931 | |
| ANAB | Anaptysbio, Inc | −51,871 | 638,161 | $35,392,409 | |
| EHTH | eHealth, Inc. | −48,632 | 1,482,797 | $1,912,808 | |
| XENE | Xenon Pharmaceuticals Inc. | −45,174 | 51,345 | $2,985,711 | |
| BIIB | Biogen Inc. | −42,852 | 140,719 | $25,798,014 | |
| NUVB | Nuvation Bio Inc. | −29,233 | 508,846 | $2,182,949 | |
| PYXS | Pyxis Oncology, Inc. | −26,911 | 1,010,510 | $1,475,344 | |
| BCYC | Bicycle Therapeutics PLC | −19,181 | 201,890 | $936,769 | |
| NVCR | NovoCure Ltd | −18,525 | 1,280,439 | $13,956,785 | |
| CRSP | CRISPR Therapeutics AG | −1,621 | 39,605 | $1,884,009 | |
| No positions match the current search. | |||||
New Positions
Positions the filer opened this quarter
5 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| CLDX | Celldex Therapeutics, Inc. | 296,408 | $9,402,061 | |
| CYTK | Cytokinetics Inc | 32,195 | $2,121,972 | |
| VSTM | Verastem, Inc. | 246,093 | $1,304,292 | |
| MDGL | Madrigal Pharmaceuticals, Inc. | 1,787 | $935,440 | |
| XERS | Xeris Biopharma Holdings, Inc. | 104,410 | $605,578 | |
| No positions match the current search. | ||||
51 positions ·
$653,863,072 total
· as of Mar 31, 2026
Showing 1–50
of 51 positions by value
· page 1 of 2
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| INSM |
INSMED Inc
Healthcare
|
Reduced | 415,269 | $67,904,786 | 10.39% | |
| ACAD |
Acadia Pharmaceuticals Inc
Healthcare
|
Added | 2,872,695 | $63,946,190 | 9.78% | |
| PTCT |
Ptc Therapeutics, Inc.
Healthcare
|
Added | 921,607 | $62,789,084 | 9.60% | |
| BMRN |
Biomarin Pharmaceutical Inc
Healthcare
|
Reduced | 685,182 | $38,705,931 | 5.92% | |
| UTHR |
UNITED THERAPEUTICS Corp
Healthcare
|
Added | 62,809 | $37,244,480 | 5.70% | |
| ANAB |
Anaptysbio, Inc
Healthcare
|
Reduced | 638,161 | $35,392,409 | 5.41% | |
| MIRM |
Mirum Pharmaceuticals, Inc.
Healthcare
|
Added | 325,175 | $30,039,666 | 4.59% | |
| DYN |
Dyne Therapeutics, Inc.
Healthcare
|
Added | 1,652,972 | $29,968,382 | 4.58% | |
| BIIB |
Biogen Inc.
Healthcare
|
Reduced | 140,719 | $25,798,014 | 3.95% | |
| IRON |
Disc Medicine, Inc.
Healthcare
|
Added | 401,719 | $25,685,912 | 3.93% | |
| IOVA |
Iovance Biotherapeutics, Inc.
Healthcare
|
Reduced | 6,349,563 | $22,286,966 | 3.41% | |
| SNDX |
Syndax Pharmaceuticals Inc
Healthcare
|
Added | 864,986 | $20,206,072 | 3.09% | |
| ANNX |
Annexon, Inc.
Healthcare
|
Added | 2,948,090 | $16,332,418 | 2.50% | |
| FOLD |
AMICUS THERAPEUTICS, INC.
Healthcare
|
Reduced | 1,113,045 | $16,094,630 | 2.46% | |
| NVCR |
NovoCure Ltd
Healthcare
|
Reduced | 1,280,439 | $13,956,785 | 2.13% | |
| RARE |
Ultragenyx Pharmaceutical Inc.
Healthcare
|
Added | 596,495 | $12,496,570 | 1.91% | |
| PRTA |
Prothena Corp Public Ltd Co
Healthcare
|
Reduced | 1,208,568 | $11,747,280 | 1.80% | |
| BCAX |
Bicara Therapeutics Inc.
Healthcare
|
Added | 550,408 | $10,947,615 | 1.67% | |
| CLDX |
Celldex Therapeutics, Inc.
Healthcare
|
NEW | 296,408 | $9,402,061 | 1.44% | |
| CDNA |
CareDx, Inc.
Healthcare
|
Added | 531,870 | $9,233,263 | 1.41% | |
| ALKS |
Alkermes plc.
Healthcare
|
Held | 242,560 | $8,576,921 | 1.31% | |
| CMPX |
Compass Therapeutics, Inc.
Healthcare
|
Reduced | 1,514,504 | $8,011,726 | 1.23% | |
| AGIO |
Agios Pharmaceuticals, Inc.
Healthcare
|
Added | 213,601 | $7,226,121 | 1.11% | |
| ALGN |
Align Technology Inc
Healthcare
|
Held | 41,520 | $7,117,773 | 1.09% | |
| CAPR |
Capricor Therapeutics, Inc.
Healthcare
|
Added | 229,763 | $6,984,795 | 1.07% | |
| TVTX |
Travere Therapeutics, Inc.
Healthcare
|
Added | 230,453 | $6,846,758 | 1.05% | |
| TSHA |
Taysha Gene Therapies, Inc.
Healthcare
|
Added | 1,391,382 | $6,219,477 | 0.95% | |
| ACRS |
Aclaris Therapeutics, Inc.
Healthcare
|
Added | 1,613,430 | $6,050,362 | 0.93% | |
| DNLI |
Denali Therapeutics Inc.
Healthcare
|
Reduced | 234,582 | $4,503,974 | 0.69% | |
| XENE |
Xenon Pharmaceuticals Inc.
Healthcare
|
Reduced | 51,345 | $2,985,711 | 0.46% | |
| ORKA |
Oruka Therapeutics, Inc.
Healthcare
|
Held | 59,985 | $2,942,264 | 0.45% | |
| STOK |
Stoke Therapeutics, Inc.
Healthcare
|
Added | 84,631 | $2,755,585 | 0.42% | |
| EW |
Edwards Lifesciences Corp
Healthcare
|
Held | 33,640 | $2,693,891 | 0.41% | |
| NBIX |
Neurocrine Biosciences Inc
Healthcare
|
Held | 18,117 | $2,386,733 | 0.37% | |
| NUVB |
Nuvation Bio Inc.
Healthcare
|
Reduced | 508,846 | $2,182,949 | 0.33% | |
| CYTK |
Cytokinetics Inc
Healthcare
|
NEW | 32,195 | $2,121,972 | 0.32% | |
| EHTH |
eHealth, Inc.
Financial Services
|
Reduced | 1,482,797 | $1,912,808 | 0.29% | |
| CRSP |
CRISPR Therapeutics AG
Healthcare
|
Reduced | 39,605 | $1,884,009 | 0.29% | |
| BNTX |
BioNTech SE
Healthcare
|
Held | 19,614 | $1,743,292 | 0.27% | |
| PYXS |
Pyxis Oncology, Inc.
Healthcare
|
Reduced | 1,010,510 | $1,475,344 | 0.23% | |
| VSTM |
Verastem, Inc.
Healthcare
|
NEW | 246,093 | $1,304,292 | 0.20% | |
| BCYC |
Bicycle Therapeutics PLC
Healthcare
|
Reduced | 201,890 | $936,769 | 0.14% | |
| MDGL |
Madrigal Pharmaceuticals, Inc.
Healthcare
|
NEW | 1,787 | $935,440 | 0.14% | |
| HUM |
Humana Inc
Healthcare
|
Held | 3,985 | $690,959 | 0.11% | |
| CMPS |
COMPASS Pathways plc
Healthcare
|
Held | 115,616 | $639,356 | 0.10% | |
| XERS |
Xeris Biopharma Holdings, Inc.
Healthcare
|
NEW | 104,410 | $605,578 | 0.09% | |
| ABEO |
Abeona Therapeutics Inc.
Healthcare
|
Held | 108,865 | $487,715 | 0.07% | |
| INSP |
Inspire Medical Systems, Inc.
Healthcare
|
Held | 8,772 | $452,459 | 0.07% | |
| URGN |
UroGen Pharma Ltd.
Healthcare
|
Held | 24,500 | $440,510 | 0.07% | |
| PRQR |
ProQR Therapeutics N.V.
Healthcare
|
Held | 188,807 | $305,867 | 0.05% |